Skip to main content
SpringerLink
Log in

Lenalidomide set to generate sales of $US321 million in 2009

  • Media release
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lenalidomide set to generate sales of $US321 million in 2009. Pharmacoecon. Outcomes News 481, 14 (2005). https://doi.org/10.2165/00151234-200504810-00034

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200504810-00034

Keywords

Search

Navigation